The clinical and biological features of a series of immunophenotypic variant of B-CLL

European Journal of Haematology

Volumn 85, Issue 2, 2010, Pages 120-129

  Cro, Lilla ^a   Ferrario, Andrea ^a   Lionetti, Marta ^a   Bertoni, Francesco ^b   Zucal N, Nadia ^a   Nobili, Lucia ^a   Fabris, Sonia ^a   Todoerti, Katia ^a   Cortelezzi, Agostino ^a   Guffanti, Andrea ^c   Goldaniga, Maria ^a   Marcheselli, Luigi ^d   Neri, Antonino ^a   Lambertenghi Deliliers, Giorgio ^a   Baldini, Luca ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND   (Switzerland)

^c FATEBENEFRATELLI HOSPITAL   (Italy)

^d UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

B cell chronic lymphocytic leukaemia; FISH analysis; IgVH gene mutations; immunophenotype; ZAP 70 expression

Indexed keywords

ALPHA4 INTEGRIN; BETA 2 MICROGLOBULIN; CD1C ANTIGEN; CD38 ANTIGEN; HEMOGLOBIN; HEPATITIS C ANTIBODY; LACTATE DEHYDROGENASE; LEUKOSIALIN; MONOCLONAL ANTIBODY; PROTEIN KINASE ZAP 70; VIRUS ANTIBODY;

ADULT; AGE DISTRIBUTION; AGED; ANTIGEN EXPRESSION; ARTICLE; B CELL LEUKEMIA; BIOLOGICAL ACTIVITY; BONE MARROW BIOPSY; CELL STRUCTURE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; CONTROLLED STUDY; CYTOFLUOROMETRY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE MUTATION; GENETIC VARIABILITY; HEMOGLOBIN BLOOD LEVEL; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOPHENOTYPING; LACTATE DEHYDROGENASE BLOOD LEVEL; LYMPHOCYTE; LYMPHOCYTOSIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; SPLENOMEGALY; THROMBOCYTE; TRISOMY; TRISOMY 12;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENE EXPRESSION PROFILING; GENE REARRANGEMENT; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 77954719731     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2010.01454.x     Document Type: Article

References (41)

1. Moreau EJ, Matutes E, A'Hern RP, Morilla AM, Morilla RM, Owusu-Ankomah KA, Seon BK, Catovsky D. Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD 79b). Am J Clin Pathol 1997 108 : 378 382.
2. Klein U, Tu Y, Stolovitzky GA, et al. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med 2001 194 : 1625 1638.
3. Chiorazzi N, Rai K, Ferrarini M. Chronic Lymphocytic Leukemia. N Engl J Med 2005 352 : 804 815.
4. Rai K, Chiorazzi N. Determining the Clinical Course and Outcome in Chronic Lymphocytic Leukemia. N Engl J Med 2003 348 : 1797 1799.
5. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999 94 : 1848 1854.
6. Damle RN, Wasil T, Fais F, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999 94 : 1840 1847.
7. Ghia P, Stamatopoulos K, Belessi C, et al. Geographic patterns and pathogenic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 gene. Blood 2005 105 : 1678 1685.
8. Caligaris Cappio F, Ghia P. The normal counterpart to the chronic lymphocyte leukemia B cell. Best Pract Res Clin Haematol 2007 20 : 385 397.
9. Matutes E, Owusu-Ankomah K, Morilla R, Garcia Marco J, Houlihan A, Que TH, Catovsky D. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia 1994 8 : 1640 1645.
10. Cro L, Guffanti A, Colombi M, et al. Diagnostic role and prognostic significance of a simplified immunophenotypic classification of mature B cell chronic lymphoid leukemias. Leukemia 2003 17 : 125 132.
11. Cheson BD, Bennett JM, Grever M, Kay N, Keating MJ, O'Brien S, Rai KR. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 1996 87 : 4990 4997.
12. Baldini L, Cro L, Calori R, Nobili L, Silvestris I, Maiolo AT. Differential expression of very late activation antigen-3 (VLA-3)/VLA4 in B-cell non-Hodgkin lymphoma and B-cell chronic lymphocytic leukemia. Blood 1992 79 : 2688 2693.
13. Del Giudice I, Morilla A, Osuji N, et al. Zeta-chain associated protein 70 and CD38 combined predict the time to first treatment in patients with chronic lymphocytic leukemia. Cancer 2005 104 : 2124 2132.
14. Crespo M, Bosch F, Villamor N, Bellosillo B, Colomer D, Rozman M, Marcé S, López-Guillermo A, Campo E, Montserrat E. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med 2003 348 : 1764 1775. (Pubitemid 36514707)
15. Agnelli L, Bicciato S, Mattioli M, et al. Molecular classification of multiple myeloma: a distinct transcriptional profile characterizes patients expressing CCND1 and negative for 14q32 translocations. J Clin Oncol 2005 23 : 7296 7306.
16. Schadt EE, Li C, Ellis B, Wong WH. Feature extraction and normalization algorithms for high-density oligonucleotide gene expression array data. J Cell Biochem Suppl 2001 37 : 120 125.
17. Mattioli M, Agnelli L, Fabris S, et al. Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myeloma. Oncogene 2005 24 : 2461 2473.
18. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001 98 : 5116 5121.
19. Fabris S, Mosca L, Todoerti K, et al. Molecular and transcriptional characterization of 17p loss in B-cell chronic lymphocytic leukemia. Genes Chromosomes Cancer 2008 47 : 781 793.
20. Kaplan EI, Meier P. Non parametric evaluation from incomplete observations. J Am Stat Assoc 1958 53 : 457 481.
21. Frater JL, McCarron K, Hammel JP, Shapiro JL, Miller ML, Tubbs RR, Pettay J, Hsi ED. Typical and Atypical Chronic Lymphocytic Leukemia Differ Clinically and Immunophenotypically. Am J Clin Pathol 2001 116 : 655 664.
22. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW. World Health Organization classification of tumours of hematopoietic and lymphoid tissues, 4th edn.
23. Bennet JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. The French-American-British (FAB) cooperative group. Proposals for the classification of chronic (mature) B and T lymphoid leukemias. J Clin Pathol 1989 42 : 567 584.
24. Carulli G, Cannizzo E, Buda G, Orciuolo E, Marini A, Petrini M. CD45 expression in low-grade B-cell non-Hodgkin's lymphomas. Leuk Res 2008 32 : 263 267.
25. Ugo V, Leporrier N, Salaun V, et al. Deciphering leukemic B-cell chronic lymphoproliferative disorders. Leuk Lymphoma 2006 47 : 2088 2095.
26. Matutes E, Oscier D, Garcia-Marco J, Ellis J, Copplestone A, Gillingham R, Hamblin T, Lens D, Swansbury GJ, Catovsky D. Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patients. Br J Haematol 1996 92 : 382 388.
27. Del Poeta G, Maurillo L, Venditti A, et al. Clinical significance of CD38 expression in chronic lymphocytic leukemia. Blood 2001 98 : 2633 2639.
28. Cro L, Morabito F, Zucal N, et al. CD26 expression in mature B cell neoplasia: its possible role as a prognostic marker in B CLL. Hematol Oncol 2009 27 : 140 147.
29. Gattei V, Bulian P, Del Principe MI, et al. Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia. Blood 2008 111 : 865 873.
30. Rassenti LZ, Huynh L, Toy TL, et al. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. N Engl J Med 2004 351 : 893 901.
31. Tobin G, Thunberg U, Johnson A, et al. Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted V{lambda}2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope. Blood 2003 101 : 4952 4957.
32. Tobin G, Soderberg O, Thunberg U, Rosenquist R. VH3-21 gene usage in chronic lymphocytic leukaemia - Characterization of a new subgroup with distinct molecular features and poor survival. Leuk Lymphoma 2004 45 : 221 228.
33. Nollet F, Cauwelier B, Billiet J, Selleslag D, Van Hoof A, Louwagie A, Criel A. Do B-cell chronic lymphocytic leukemia patients with Ig VH3-21 genes constitute a new subset of chronic lymphocytic leukemia? Blood 2002 100 : 1097 1098.
34. Martin-Jimenez P, Garcia Sanz R, Balanzategui A, Alcoceba M, Ocio E, Sanchez ML, González M, San Miguel J. Molecular characterization of heavy chain immunoglobulin gene rearrangements in Waldenstrom's macroglobulinemia and IgM monoclonal gammopathy of undetermined significante. Haematologica 2007 92 : 635 642.
35. Arons E, Sunshine J, Suntum T, Kreitman RJ. Somatic hypermutation and VH gene usage in hairy cell leukemia. Br J Haematol 2006 133 : 504 512.
36. Shehata M, Weidenhofer J, Thamotharampillai K, Hardy JR, Byrne JA. Tumor protein D52 overexpression and gene amplification in cancers from a mosaic of microarrays. Crit Rev Oncog 2008 14 : 33 55.
37. Endo T, Nishio M, Enzler T, Cottam HB, Fukuda T, James DF, Karin M, Kipps TJ. BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-kappaB pathway. Blood 2006 109 : 703 710.
38. Zheng Z, Venkatapathy S, Rao G, Harrington CA. Expression profiling of B cell chronic lymphocytic leukemia suggests deficient CD1-mediated immunity, polarized cytokine response, altered adhesion and increased intracellular protein transport and processing of leukemic cells. Leukemia 2002 16 : 2429 2437.
39. Chng WJ, Schop RF, Price-Toska T, et al. Gene-expression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myeloma. Blood 2006 108 : 2755 2763.
40. Shanafelt TD, Geyer SM, Bone ND, et al. CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential. Br J Haematol 2008 140 : 537 546.
41. Lúcio PJ, Faria MT, Pinto AM, da Silva MR, Correia Júnior ME, da Costa RJ, Parreira AB. Expression of adhesion molecules in chronic B-cell lymphoproliferative disorders. Haematologica 1998 83 : 104 111.